PreComb Therapeutics AG

PreComb Therapeutics AG is a privately held Swiss biotech company developing proprietary technologies bringing functional precision medicine to clinical practice and enabling evidence-based treatment decisions in cancer. The founding and management team combines their longstanding expertise in 3D cell culture technologies, life science process automation, computational and drug development. PreComb's proprietary 3DTwin® technology combines fully automated and clinically relevant drug testing with patient-derived biological tumor twins, AI-guided data analysis and response prediction. It is engineered for on-site use directly in the clinic in both oncology research and precision medicine. Together we are advancing personalized oncology for the best possible benefit of patients